Breast Cancer

NeuVax + Herceptin may provide a clinically meaningful benefit to breast cancer patients with low to intermediate HER2-expression.

The 40th anniversary of the San Antonio Breast Cancer Symposium was attended by approximately 8000 healthcare professionals and featured presentations ranging from basic science to preliminary clinical trials and new standards of care. Below is a summary of key presentations featured at the press conferences.

The current US Preventive Services Task Force guidelines call for breast cancer screening every 2 years for women between the ages of 50 and 75 years.

Older patients with hormone receptor–positive, HER2-negative, metastatic breast cancer derive similar benefit as younger patients treated with CDK4/6 inhibitors as part of initial endocrine therapy, according to a pooled analysis of registration trials presented at the 2017 San Antonio Breast Cancer Symposium.

Navigating patients through the complexities of breast cancer is a unique challenge, but cross-collaboration between breast patient navigators and oncology nurse navigators can make a world of difference in improving patient care.

The authors examine and assess the effect of a nurse navigator home visit in reducing distress among women who have been newly diagnosed with breast cancer.

Today there are ever-increasing challenges surrounding breast cancer care. The ongoing disparities in delivering cancer care continue to impact our nation as a whole, and, more importantly, for both patients and providers in our local communities.

Each woman’s risk of developing breast cancer is different and depends on her lifestyle, family health history, and other factors. The American Cancer Society considers women who have a lifetime risk assessment of 20% or greater to be at high risk for breast cancer.

The authors present their findings from a study testing the effects of an early intervention by the Breast Cancer Navigator on distress.

Transitions in care require well-managed timing and sequencing of events across specialties.